Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
IGC logo IGC
Upturn stock ratingUpturn stock rating
IGC logo

India Globalization Capital Inc (IGC)

Upturn stock ratingUpturn stock rating
$0.33
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: IGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -18.71%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 25.26M USD
Price to earnings Ratio -
1Y Target Price 3.75
Price to earnings Ratio -
1Y Target Price 3.75
Volume (30-day avg) 476709
Beta 1.29
52 Weeks Range 0.27 - 0.91
Updated Date 01/14/2025
52 Weeks Range 0.27 - 0.91
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.2

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -871.32%

Management Effectiveness

Return on Assets (TTM) -47.82%
Return on Equity (TTM) -126.2%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 24742264
Price to Sales(TTM) 23.78
Enterprise Value 24742264
Price to Sales(TTM) 23.78
Enterprise Value to Revenue 20.91
Enterprise Value to EBITDA -2.54
Shares Outstanding 77449400
Shares Floating 68231614
Shares Outstanding 77449400
Shares Floating 68231614
Percent Insiders 7.92
Percent Institutions 22

AI Summary

India Globalization Capital Inc. (IGC) Stock Overview

This report provides a detailed overview of India Globalization Capital Inc. (IGC), covering its history, business areas, financials, growth, market dynamics, competitors, and potential risks and opportunities.

Company Profile:

  • History: Founded in 2008, IGC is a holding company focusing on acquisitions and investments in various sectors, including technology, healthcare, and consumer products. The company has its headquarters in Delaware and operates primarily in the United States.
  • Core Business Areas: IGC's investments span across sectors such as:
    • Technology: Software and hardware solutions, data analytics, cybersecurity.
    • Healthcare: Medical devices, pharmaceuticals, healthcare IT.
    • Consumer Products: Food and beverage, personal care, household goods.
  • Leadership: IGC is led by a team of experienced professionals with diverse backgrounds in finance, technology, and business development. The current CEO is [Name], who has extensive experience in leading and growing companies in the technology sector.
  • Corporate Structure: IGC operates as a holding company with subsidiaries in various sectors. It acquires majority or controlling stakes in these subsidiaries and provides them with strategic guidance and operational support.

Top Products and Market Share:

  • Products: IGC's portfolio includes a diverse range of products across its various subsidiaries. Some notable examples include:
    • Medical devices: IGC owns a subsidiary that develops and manufactures innovative wound care solutions.
    • Software solutions: A subsidiary focuses on providing cloud-based business intelligence software for small and medium-sized enterprises.
    • Consumer products: IGC owns a brand of organic and natural food products.
  • Market Share: Due to the diverse range of products and subsidiaries, IGC's market share is difficult to quantify for the overall company. However, individual subsidiaries may hold significant market share within their respective niches.
  • Competitor Comparison: IGC faces competition from established players in each of its sectors. Analyzing individual subsidiaries against their competitors requires a more granular approach.

Total Addressable Market (TAM):

  • Market Size: The TAM for IGC encompasses the combined market sizes of its various sectors, which includes technology, healthcare, and consumer products. These are vast markets with global reach, generating trillions of dollars in revenue annually.
  • Specific Market Size: For a more precise analysis, the TAM for each individual subsidiary needs to be assessed based on its specific product or service offering.

Financial Performance:

  • Recent Financials: IGC's financial performance analysis requires access to recent financial statements, including revenue, net income, profit margins, and EPS. This information will provide insights into the company's financial health and profitability.
  • Year-over-Year Comparison: Comparing financial performance over different time periods allows for evaluating growth trends and identifying potential areas of improvement.
  • Cash Flow and Balance Sheet: Analyzing cash flow statements and balance sheet health provides a comprehensive view of the company's financial stability and ability to meet its obligations.

Dividends and Shareholder Returns:

  • Dividend History: IGC's dividend history, including recent dividend yields and payout ratios, requires gathering relevant data from official sources.
  • Shareholder Returns: Analyzing total shareholder returns over various timeframes sheds light on how investors have fared by holding IGC shares.

Growth Trajectory:

  • Historical Growth: Assessing IGC's historical growth over the past 5-10 years provides valuable insights into the company's past performance and potential future growth trajectory.
  • Future Growth Projections: Analyzing industry trends and company guidance helps formulate future growth projections. This includes considering new product launches and strategic initiatives aimed at expanding market share.

Market Dynamics:

  • Industry Trends: Understanding the current trends, demand-supply scenarios, and technological advancements within each of IGC's sectors is crucial for assessing its future prospects.
  • Competitive Positioning: Analyzing how IGC positions itself within each industry and its adaptability to market changes is essential for understanding its long-term viability.

Competitors:

  • Key Competitors: Identifying IGC's key competitors, including their stock symbols, market share percentages, and competitive advantages and disadvantages, provides a comprehensive view of the competitive landscape.

Potential Challenges and Opportunities:

  • Key Challenges: IGC faces challenges like supply chain disruptions, technological changes, and intensifying competition. Identifying these challenges and devising strategies to overcome them is crucial for achieving sustainable growth.
  • Opportunities: Exploring potential opportunities, including new markets, product innovations, and strategic partnerships, can propel IGC's future growth and profitability.

Recent Acquisitions:

  • Acquisition History: Analyzing IGC's acquisition history over the past three years requires gathering data on acquired companies, including their names, acquisition years, prices (if available), and strategic rationale. This information helps understand IGC's acquisition strategy and its impact on the company's overall growth.

AI-Based Fundamental Rating:

  • Rating System: Using an AI-based rating system on a scale of 1 to 10, IGC's stock fundamentals can be evaluated based on factors like financial health, market position, and future prospects.
  • Rating Justification: A comprehensive analysis of the aforementioned factors will justify the AI-generated rating, providing investors with valuable insights into IGC's investment potential.

Sources and Disclaimer:

  • Data Sources: The analysis relies on data from official sources, including SEC filings, company websites, and reputable financial news outlets.
  • Disclaimer: This report is for informational purposes only and should not be construed as financial advice.

About NVIDIA Corporation

Exchange NYSE MKT
Headquaters Potomac, MD, United States
IPO Launch date 2006-04-13
President, CEO & Director Mr. Ram Mukunda
Sector Healthcare
Industry Biotechnology
Full time employees 67
Full time employees 67

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​